- This event has passed.
Events listed on BioOhio's Events Calendar are subject to change by the Event Organizer. Visit the organizer's website for current details.
Nationwide Children’s Hospital Technology Showcase
March 4 @ 1:00 pm - 3:00 pm
Learn about impactful innovations as well as new start-up companies generated from the Abigail Wexner Research Institute at Nationwide Children’s Hospital. The Nationwide Children’s Hospital Technology Showcase is hosted by The Office of Technology Commercialization.
Presentations will include:
Gene Therapy for FSHD – Presenter: Scott Harper, PhD. Dr. Harper will discuss translation of a gene silencing therapy for one of the most common forms of muscular dystrophy.
Genome Editing to Express Full-Length Dystrophin in Duchenne Muscular Dystrophy – Presenter: Kevin Flanigan, MD. Genome editing approaches allow the possibility of expression of full-length dystrophin (rather than engineered miniaturized dystrophin) in the muscle of boys with DMD.
Advancing Development and Recovery Through Movement – Presenter: Marissa Koscielski, MS, Founder Enlighten Mobility. Explore groundbreaking solutions in early intervention designed to establish improved care pathways for patients with loss of mobility and review initial findings from ongoing clinical studies of non-invasive neuromotor screening, led by Nathalie Maitre, MD, PhD, and autonomous gait training for lower-limb amputees immediately following surgery.
Development of a Humanized Monoclonal Antibody as a Unique Therapy for Infections Caused by Bacterial Biofilms – Presenter: Charles McOsker, PhD, Co-founder & Chief Scientific Officer, Clarametyx Biosciences. Clarametyx Biosciences is developing licensed technology from Nationwide Children’s Hospital that rapidly collapses bacterial biofilms in a pathogen-agnostic fashion; the first clinical evaluation of this technology will occur in patients hospitalized with bacterial pneumonia.
This event will be presented virtually via Vimeo.
